NEW YORK — The head of the Johnson & Johnson division responsible for most of the company's 11 product recalls announced her retirement late Thursday, shortly after a congressional committee probing the recalls invited her to a second hearing.

J&J, reeling from an unprecedented spate of recalls that includes more than 135 million bottles of infants' and children's Tylenol and other nonprescription medicines, said Colleen Goggins will retire on March 1 after almost 30 years with the company.

The House Committee on Oversight and Government Reform released some internal J&J e-mails it uncovered indicating that before all the official recalls over the last year, the company conducted a "phantom recall" of Motrin packages with questionable potency.

J&J's once-golden reputation has been severely tarnished by nine recalls of nonprescription medicines, one of contact lenses and one of hip implants in 11 months.